LIN · Earnings call · 2026Q3T · Full report

Revenue Performance and Mix

LINDE PLC · 2026-10-29 · Importance 42 · Surprise 14 · No source text

Third-quarter sales were $9.4 billion, up 9% year over year, with underlying sales growth of 5% after currency, cost pass-through, acquisitions, and engineering contributions. Volume increased 2% and prices increased 3%; currency, cost pass-through, acquisitions, and engineering each contributed 1% to sales growth. Electronics grew 15%, Chemicals & Energy grew 12%, manufacturing grew 7%, Food & Beverage and metals and mining each grew 3%, and healthcare grew 2%; healthcare growth was mid-single digit excluding Lincare. Lincare’s year-to-date performance reduced EPS growth by approximately 1.5% to 2%, while its annualized sales are about $2.3 billion.

Key facts

• LINDE PLC’s Q3 2026 sales of $9.4 billion increased 9% year over year; currency contributed 1%, cost pass-through 1%, acquisitions 1% and engineering 1%, while underlying sales grew 5%.
• LINDE PLC reported quarterly-record sales of $9.4 billion, operating profit of $2.8 billion and EPS of $4.59 in Q3 2026.
• LINDE PLC said Lincare reduced year-to-date EPS growth by about 1.5%–2%, projected through the year while holding Q4 flat.
• LINDE PLC said about 2 percentage points of the Americas’ 6% pricing in Q3 was cost recovery, leaving an underlying run rate around 4%.
• LINDE PLC said its underlying global pricing run rate was around 4% excluding recovery, while APAC pricing was about half helium-related and the other half reflected traction in South Pacific and India.
• LINDE PLC’s Q3 2026 volume growth was 2%, roughly split between project-backlog contribution and organic growth; most organic growth related to equipment sales in APAC and EMEA.
• LINDE PLC’s prices increased 3% in Q3 2026, mostly from ongoing price actions, with part related to recovery of prior- and current-period inflation costs in the Americas.
• LINDE PLC’s Q3 2026 EPS of $4.59 grew 9% year over year, or 8% excluding currency; Lincare reduced year-to-date EPS growth by about 2%.

Impact estimates